Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 608438, 9 pages
http://dx.doi.org/10.1155/2015/608438
Review Article

Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies

Department of Pneumology, University Hospital of Marburg, Campus Fulda, Pacelliallee 4, 36043 Fulda, Germany

Received 17 December 2014; Revised 6 May 2015; Accepted 28 May 2015

Academic Editor: Jacek Zielonka

Copyright © 2015 Hans-Joachim Eisele et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Younes, “Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders,” Journal of Applied Physiology, vol. 105, no. 5, pp. 1389–1405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Young, P. E. Peppard, and D. J. Gottlieb, “Epidemiology of obstructive sleep apnea: a population health perspective,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 9, pp. 1217–1239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, “The occurrence of sleep-disordered breathing among middle-aged adults,” The New England Journal of Medicine, vol. 328, no. 17, pp. 1230–1235, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. C. E. Woods, K. Usher, and G. P. Maguire, “Obstructive sleep apnoea in adult indigenous populations in high-income countries: an integrative review,” Sleep and Breathing, vol. 19, no. 1, pp. 45–53, 2015. View at Publisher · View at Google Scholar
  5. J. M. Marin, S. J. Carrizo, E. Vicente, and A. G. N. Agusti, “Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study,” The Lancet, vol. 365, no. 9464, pp. 1046–1053, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. E. Sullivan, F. G. Issa, M. Berthon-Jones, and L. Eves, “Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares,” The Lancet, vol. 1, no. 8225, pp. 862–865, 1981. View at Google Scholar · View at Scopus
  7. R. Dumitrascu, J. Heitmann, W. Seeger, N. Weissmann, and R. Schulz, “Obstructive sleep apnea, oxidative stress and cardiovascular disease: lessons from animal studies,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 234631, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Marrone and M. R. Bonsignore, “Pulmonary haemodynamics in obstructive sleep apnoea,” Sleep Medicine Reviews, vol. 6, no. 3, pp. 175–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Guilleminault, S. Connolly, and R. Winkle, “Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique,” The Lancet, vol. 1, no. 8369, pp. 126–131, 1984. View at Publisher · View at Google Scholar · View at Scopus
  10. V. A. Rossi, J. R. Stradling, and M. Kohler, “Effects of obstructive sleep apnoea on heart rhythm,” European Respiratory Journal, vol. 41, no. 6, pp. 1439–1451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Gami, E. J. Olson, W. K. Shen et al., “Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults,” Journal of the American College of Cardiology, vol. 62, no. 7, pp. 610–616, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wolf, D. Hering, and K. Narkiewicz, “Non-dipping pattern of hypertension and obstructive sleep apnea syndrome,” Hypertension Research, vol. 33, no. 9, pp. 867–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. G. Logan, S. M. Perlikowski, A. Mente et al., “High prevalence of unrecognized sleep apnoea in drug-resistant hypertension,” Journal of Hypertension, vol. 19, no. 12, pp. 2271–2277, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-P. Baguet, P. Lévy, G. Barone-Rochette et al., “Masked hypertension in obstructive sleep apnea syndrome,” Journal of Hypertension, vol. 26, no. 5, pp. 885–892, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. H. Mason, G. Ruegg, J. Perkins et al., “Obstructive sleep apnea in patients with abdominal aortic aneurysms: highly prevalent and associated with aneurysm expansion,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 5, pp. 668–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Sajkov, T. Wang, N. A. Saunders, A. J. Bune, A. M. Neill, and R. D. McEvoy, “Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 5 I, pp. 1518–1526, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Arzt, R. Luigart, C. Schum et al., “Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism,” European Respiratory Journal, vol. 40, no. 4, pp. 919–924, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. T. Carlson, C. Rångemark, and J. A. Hedner, “Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea,” Journal of Hypertension, vol. 14, no. 5, pp. 577–584, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Schulz, W. Seeger, C. Fegbeutel et al., “Changes in extracranial arteries in obstructive sleep apnoea,” European Respiratory Journal, vol. 25, no. 1, pp. 69–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Campos-Rodriguez, M. A. Martinez-Garcia, I. de la Cruz-Moron, C. Almeida-Gonzalez, P. Catalan-Serra, and J. M. Montserrat, “Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study,” Annals of Internal Medicine, vol. 156, no. 2, pp. 115–122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-A. Martínez-García, F. Campos-Rodríguez, P. Catalán-Serra et al., “Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 9, pp. 909–916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. F. P. Cappuccio, D. Cooper, L. D'Elia, P. Strazzullo, and M. A. Miller, “Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies,” European Heart Journal, vol. 32, no. 12, pp. 1484–1492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Sofi, F. Cesari, A. Casini, C. Macchi, R. Abbate, and G. F. Gensini, “Insomnia and risk of cardiovascular disease: a meta-analysis,” European Journal of Preventive Cardiology, vol. 21, no. 1, pp. 57–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Gupta and K. Knapp, “Cardiovascular and psychiatric morbidity in Obstructive Sleep Apnea (OSA) with Insomnia (sleep apnea plus) versus obstructive sleep apnea without insomnia: a case-control study from a nationally representative US sample,” PLoS ONE, vol. 9, no. 3, Article ID e90021, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. V. K. Somers, M. E. Dyken, M. P. Clary, and F. M. Abboud, “Sympathetic neural mechanisms in obstructive sleep apnea,” The Journal of Clinical Investigation, vol. 96, no. 4, pp. 1897–1904, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. A. K. Htoo, H. Greenberg, S. Tongia et al., “Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation,” Sleep and Breathing, vol. 10, no. 1, pp. 43–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. A. Gharib, A. L. Hayes, M. J. Rosen, and S. R. Patel, “A pathway-based analysis on the effects of obstructive sleep apnea in modulating visceral fat transcriptome,” Sleep, vol. 36, no. 1, pp. 23–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. B. G. Phillips, K. Narkiewicz, C. A. Pesek, W. G. Haynes, M. E. Dyken, and V. K. Somers, “Effects of obstructive sleep apnea on endothelin-1 and blood pressure,” Journal of Hypertension, vol. 17, no. 1, pp. 61–66, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Schulz, C. Hummel, S. Heinemann, W. Seeger, and F. Grimminger, “Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 1, pp. 67–70, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Bokinsky, M. Miller, K. Ault, P. Husband, and J. Mitchell, “Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation,” Chest, vol. 108, no. 3, pp. 625–630, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. M. de la Peña, A. Barceló, F. Barbe et al., “Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome,” Respiration, vol. 76, no. 1, pp. 28–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. S. M. Ip, B. Lam, M. M. T. Ng, W. K. Lam, K. W. T. Tsang, and K. S. L. Lam, “Obstructive sleep apnea is independently associated with insulin resistance,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 5, pp. 670–676, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Adedayo, O. Olafiranye, D. Smith et al., “Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism,” Sleep and Breathing, vol. 18, no. 1, pp. 13–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Sies, “Oxidative stress: a concept in redox biology and medicine,” Redox Biology, vol. 4, pp. 180–183, 2015. View at Publisher · View at Google Scholar
  35. B. Halliwell, “Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?” The Lancet, vol. 344, no. 8924, pp. 721–724, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Halliwell, “The role of oxygen radicals in human disease, with particular reference to the vascular system,” Haemostasis, vol. 23, no. 1, pp. 118–126, 1993. View at Google Scholar · View at Scopus
  37. S. Cofta, E. Wysocka, T. Piorunek, M. Rzymkowska, H. Batura-Gabryel, and L. Torlinski, “Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome,” Journal of Physiology and Pharmacology, vol. 59, no. 6, pp. 183–190, 2008. View at Google Scholar · View at Scopus
  38. K. Katsoulis, T. Kontakiotis, D. Spanogiannis et al., “Total antioxidant status in patients with obstructive sleep apnea without comorbidities: the role of the severity of the disease,” Sleep and Breathing, vol. 15, no. 4, pp. 861–866, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Papandreou, “Levels of TBARS are inversely associated with lowest oxygen saturation in obese patients with OSAS,” Sleep and Breathing, vol. 17, no. 4, pp. 1319–1322, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Svatikova, R. Wolk, L. O. Lerman et al., “Oxidative stress in obstructive sleep apnoea,” European Heart Journal, vol. 26, no. 22, pp. 2435–2439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Schulz, S. Mahmoudi, K. Hattar et al., “Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 2, part 1, pp. 566–570, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Dyugovskaya, P. Lavie, and L. Lavie, “Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 7, pp. 934–939, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. H.-G. Liu, K. Liu, Y.-N. Zhou, and Y.-J. Xu, “Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population,” Chinese Medical Journal, vol. 122, no. 12, pp. 1369–1374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Del Ben, M. Fabiani, L. Loffredo et al., “Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment,” BMC Pulmonary Medicine, vol. 12, article 36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. P. J. Andrew and B. Mayer, “Enzymatic function of nitric oxide synthases,” Cardiovascular Research, vol. 43, no. 3, pp. 521–531, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. J. L. Boucher, C. Moali, and J. P. Tenu, “Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization,” Cellular and Molecular Life Sciences, vol. 55, no. 8-9, pp. 1015–1028, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Imai, “Cyclic GMP as a second messenger in the cardiovascular system,” Japanese Heart Journal, vol. 36, no. 2, pp. 127–177, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. R. A. Cohen, “The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease,” Progress in Cardiovascular Diseases, vol. 38, no. 2, pp. 105–128, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. W. H. Koppenol, J. J. Moreno, W. A. Pryor, H. Ischiropoulos, and J. S. Beckman, “Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide,” Chemical Research in Toxicology, vol. 5, no. 6, pp. 834–842, 1992. View at Publisher · View at Google Scholar · View at Scopus
  50. Z. S. Katusic, “Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?” American Journal of Physiology—Heart and Circulatory Physiology, vol. 281, no. 3, pp. H981–H986, 2001. View at Google Scholar · View at Scopus
  51. F. Arrigoni, B. Ahmetaj, and J. Leiper, “The biology and therapeutic potential of the DDAH/ADMA pathway,” Current Pharmaceutical Design, vol. 16, no. 37, pp. 4089–4102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Schulz, D. Schmidt, A. Blum et al., “Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy,” Thorax, vol. 55, no. 12, pp. 1046–1051, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. M. S. M. Ip, B. Lam, L.-Y. Chan et al., “Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2166–2171, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Alonso-Fernández, F. García-Río, M. A. Arias et al., “Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial,” Thorax, vol. 64, no. 7, pp. 581–586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Ozkan, H. Firat, B. Şimşek, M. Torun, and S. Yardim-Akaydin, “Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS),” Sleep and Breathing, vol. 12, no. 2, pp. 149–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Barceló, M. de la Peña, O. Ayllón et al., “Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea,” Respiration, vol. 77, no. 1, pp. 85–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Yüksel, H. K. Okur, Z. Pelin, A. V. Öğünç, and L. Öztürk, “Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome,” Clinics, vol. 69, no. 4, pp. 247–252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Barceló, C. Miralles, F. Barbé, M. Vila, S. Pons, and A. G. N. Agustí, “Abnormal lipid peroxidation in patients with sleep apnoea,” European Respiratory Journal, vol. 16, no. 4, pp. 644–647, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Lavie, A. Vishnevsky, and P. Lavie, “Evidence for lipid peroxidation in obstructive sleep apnea,” Sleep, vol. 27, no. 1, pp. 123–128, 2004. View at Google Scholar · View at Scopus
  60. G. E. Carpagnano, S. A. Kharitonov, O. Resta, M. P. Foschino-Barbaro, E. Gramiccioni, and P. J. Barnes, “8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy,” Chest, vol. 124, no. 4, pp. 1386–1392, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. G. L. Milne, Q. Dai, and L. J. Roberts II, “The isoprostanes—25 years later,” Biochimica et Biophysica Acta, vol. 1851, no. 4, pp. 433–445, 2015. View at Publisher · View at Google Scholar
  62. S. Ozben, N. Huseyinoglu, F. Hanikoglu et al., “Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea,” European Journal of Clinical Investigation, vol. 44, no. 11, pp. 1045–1052, 2014. View at Publisher · View at Google Scholar
  63. E. Hopps, B. Canino, V. Calandrino, M. Montana, R. Lo Presti, and G. Caimi, “Lipid peroxidation and protein oxidation are related to the severity of OSAS,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 24, pp. 3773–3778, 2014. View at Google Scholar
  64. M. Yamauchi, H. Nakano, J. Maekawa et al., “Oxidative stress in obstructive sleep apnea,” Chest, vol. 127, no. 5, pp. 1674–1679, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Xie, J. Jiang, K. Shi et al., “DNA damage in peripheral blood lymphocytes from patients with OSAHS,” Sleep and Breathing, vol. 18, no. 4, pp. 775–780, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. S. Kim, J. W. Kwak, K. E. Lee et al., “Can mitochondrial dysfunction be a predictive factor for oxidative stress in patients with obstructive sleep apnea?” Antioxidants & Redox Signaling, vol. 21, no. 9, pp. 1285–1288, 2014. View at Google Scholar
  67. K. Christou, A. N. Moulas, C. Pastaka, and K. I. Gourgoulianis, “Antioxidant capacity in obstructive sleep apnea patients,” Sleep Medicine, vol. 4, no. 3, pp. 225–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Barceló, F. Barbé, M. de la Peña et al., “Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment,” European Respiratory Journal, vol. 27, no. 4, pp. 756–760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Faure, R. Tamisier, J.-P. Baguet et al., “Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome,” European Respiratory Journal, vol. 31, no. 5, pp. 1046–1053, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Wysocka, S. Cofta, M. Cymerys, J. Gozdzik, L. Torlinski, and H. Batura-Gabryel, “The impact of the sleep apnea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients,” Journal of Physiology and Pharmacology, vol. 59, supplement 6, pp. 761–769, 2008. View at Google Scholar · View at Scopus
  71. M. S. Hoffmann, P. Singh, R. Wolk, A. Romero-Corral, S. Raghavakaimal, and V. K. Somers, “Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea,” Antioxidants and Redox Signaling, vol. 9, no. 6, pp. 661–669, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Jelic, M. Padeletti, S. M. Kawut et al., “Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea,” Circulation, vol. 117, no. 17, pp. 2270–2278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. B. T. Patt, D. Jarjoura, D. N. Haddad et al., “Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea,” The American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 12, pp. 1540–1545, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Varadharaj, K. Porter, A. Pleister et al., “Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction,” Respiratory Physiology & Neurobiology, vol. 207, pp. 40–47, 2015. View at Publisher · View at Google Scholar
  75. M. S. M. Ip, H.-F. Tse, B. Lam, K. W. T. Tsang, and W.-K. Lam, “Endothelial function in obstructive sleep apnea and response to treatment,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 3, pp. 348–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Ohike, K. Kozaki, K. Iijima et al., “Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure: possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine,” Circulation Journal, vol. 69, no. 2, pp. 221–226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Loffredo, A. M. Zicari, F. Occasi et al., “Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: role of NADPH oxidase,” Atherosclerosis, vol. 240, no. 1, pp. 222–227, 2015. View at Publisher · View at Google Scholar
  78. D. Monneret, J.-L. Pepin, D. Godin-Ribuot et al., “Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients,” Free Radical Biology and Medicine, vol. 48, no. 4, pp. 619–625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Grebe, H. J. Eisele, N. Weissmann et al., “Antioxidant vitamin C improves endothelial function in obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 8, pp. 897–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. N. J. Büchner, I. Quack, M. Woznowski, C. Stähle, U. Wenzel, and L. C. Rump, “Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy,” Respiration, vol. 82, no. 5, pp. 409–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. A. A. El Solh, R. Saliba, T. Bosinski, B. J. B. Grant, E. Berbary, and N. Miller, “Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study,” European Respiratory Journal, vol. 27, no. 5, pp. 997–1002, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. R. Schulz, G. Murzabekova, B. Egemnazarov et al., “Arterial hypertension in a murine model of sleep apnea: role of NADPH oxidase 2,” Journal of Hypertension, vol. 32, no. 2, pp. 300–305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. N. R. Prabhakar, G. K. Kumar, and Y.-J. Peng, “Sympatho-adrenal activation by chronic intermittent hypoxia,” Journal of Applied Physiology, vol. 113, no. 8, pp. 1304–1310, 2012. View at Publisher · View at Google Scholar · View at Scopus